Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-SPY COVID TRIAL
NCT04488081Phase 2Active, not recruiting
- Sponsor
- Quantum Leap Healthcare Collaborative
- Start
- Jul 2020
- Primary completion
- Jul 2028
- Modality
- Monoclonal Antibodies, Replacement Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib, cenicriviroc, icatibant, apremilast, dornase alfa in coronavirus disease 2019 (COVID-19), sponsored by Quantum Leap Healthcare Collaborative. Started Jul 2020; status: active, not recruiting.
02
Drugs
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04488081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04488081.